Kaiser Permanente

Baldwin Park, California 91706

0 studies enrolling now · 3 studies all time

What they study most

Acute Anemia, Critical COVID-19 With Respiratory Failure, HER2-Positive Primary Breast Cancer, Residual Invasive Breast Cancer

Studies at this site

• A Study of Trastuzumab Deruxtecan (T-DXd) Versus Trastuzumab Emtansine (T-DM1) in High-risk HER2-positive Participants With Residual Invasive Breast Cancer Following Neoadjuvant Therapy (DESTINY-Breast05) — Running, not enrolling
• ZYESAMI (Aviptadil) Intermediate Population Expanded Access Protocol (SAMICARE) — NO_LONGER_AVAILABLE
• A Phase 1 Safety Study of SANGUINATE™ In Patients With Acute Severe Anemia. — Completed